HERON THERAPEUTICS, INC. /DE/ insider trading activity

Understanding Insider Activity at HERON THERAPEUTICS, INC. /DE/

Welcome to our dedicated page for HERON THERAPEUTICS, INC. /DE/ (Nasdaq: HRTX) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by HERON THERAPEUTICS, INC. /DE/'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for HERON THERAPEUTICS, INC. /DE/, and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for HRTX
TickerTime & DateFilingLink
HRTX5:19:26 PM, 11/21/2023
Forbes William P(EVP, Chief Development Officer) purchased 25000 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX) for ~$27250
Filing
HRTX5:37:52 PM, 11/17/2023
Collard Craig A(Chief Executive Officer) purchased 150000 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX) for ~$138000
Filing
HRTX5:36:50 PM, 11/17/2023
Duarte Ira(EVP, Chief Financial Officer) purchased 85000 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX) for ~$75650
Filing
HRTX8:22:46 PM, 7/25/2023
Morgan Adam purchased 2486744 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX) for ~$3406839
Filing